Cargando…
Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials
Recurrence is a major concern for adult patients with glioblastomas (GBMs), and the prognosis remains poor. Although several therapies have been assessed, most of them have not achieved satisfactory results. Therefore, there is currently no standard treatment for adult recurrent GBM (rGBM). Here, we...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286895/ https://www.ncbi.nlm.nih.gov/pubmed/34321837 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.12 |